Skip to Content

Aptilon Announces the Signing of an Important Enterprise Commitment with Merck & Co.

MONTREAL, July 3 /CNW Telbec/ - Aptilon Corporation (TSX.V: APZ), a leading provider of physician access through its innovative alternative sales and marketing channel today announced that Merck & Co., Inc. has renewed its relationship with Aptilon's AxcelRx(SM) Live. Merck uses the company's video detailing software platform and hopes to increase the number of potential physician users who are interested in participating via Aptilon's ReachNet physician access network. Merck has renewed its agreement for a term of one-year for an undisclosed amount. The revenues generated from this agreement are two-fold, including both fixed fees to license, manage and support the platform as well as performance fees that will vary based upon usage.

Physicians' increasing patient loads and administrative burdens have made access for sales representatives more difficult, particularly during traditional office hours. Many hospitals and group practices now restrict or prohibit sales representative visits. The corresponding decline in representative productivity has led to searches for new, efficient and effective means of reaching and educating prescribers.

Aptilon President, Denis Martineau, said, "Merck's expanded commitment to the AxcelRx alternative sales channel is a validation of its marketplace effectiveness and a demonstration of our "Sales Force of the Future" strategic approach that enhances sales force access and addresses productivity, an issue that all pharmaceutical companies face today."

Aptilon's AxcelRx Live video detailing program serves health care professionals when and where they are accessible, even at home, during nights and weekends. Aptilon's current rep-physician interactions are averaging more than 8 minutes and achieve high levels of physician satisfaction.
Aptilon has successfully enabled large numbers of rep-physician interactions for Merck and other health care companies, accessing more than 450,000 opted-in physicians through Aptilon's ReachNet physician access channel, an extensive network of partner and company-owned websites. Aptilon's daily, high-volume outreach activity provides live interactions between sales representatives and selected, high-prescribing health care professionals who in many cases are not accessible during normal practice hours.

About Aptilon

Aptilon enables pharmaceutical, biotech and medical device companies to effectively reach and interact with physicians via the Internet through its innovative AxcelRx Live video detailing (with company reps), virtual programs, peer selling and other sales and marketing programs. Leading health care companies have adopted Aptilon's "Sales Force of the Future" model, driving tens of thousands of high-quality rep-physician interactions averaging almost 10 minutes in length. Aptilon provides the infrastructure necessary for sales representatives to build physician awareness, understanding and preference during all stages of a products life cycle, from pre-launch education through end stage support. For more information, visit

Forward-looking statements

This news release contains forward-looking information. These statements relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on information currently available
to management of Aptilon. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Aptilon does not assume any
obligation to update or revise them to reflect new events or circumstances.


/For further information: For U.S. Media: Mark Gleason, Aptilon
Corporation, (847) 331-8628,; Jed Weiner, White Oak
Communications, (847) 910-1330,; For Canadian Media:
Alexandra Malka, Aptilon Corporation, (514) 889-0961,

Posted: July 2007